These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11010631)

  • 1. From Chakrabarty to chimeras: the growing need for evolutionary biology in patent law.
    Iwasaka RM
    Yale Law J; 2000 Apr; 109(6):1505-34. PubMed ID: 11010631
    [No Abstract]   [Full Text] [Related]  

  • 2. The human use of humanoid beings: chimeras and patent law.
    Rabin S
    Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human chimera patent initiative.
    Newman SA
    Med Ethics (Burlingt Mass); 2002; 9(1):4, 7. PubMed ID: 15584183
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property rights in agriculture in the light of the debate on biotechnology: historical evolution and current situation.
    Gimelli F
    Ital J Biochem; 2000; 49(3-4):41-51. PubMed ID: 11508056
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents on human-animal chimeras and threats to human dignity.
    Resnik DB
    Am J Bioeth; 2003; 3(3):35-6. PubMed ID: 14594487
    [No Abstract]   [Full Text] [Related]  

  • 6. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human or animal: a resolution to the biotechnological blurring of the lines.
    Cirlin L
    Southwest Univ Law Rev; 2003; 32(3):501-25. PubMed ID: 15212023
    [No Abstract]   [Full Text] [Related]  

  • 8. Foreword: what hath (not) Chakrabarty wrought: from the mouse that roared to Hello Dolly and beyond.
    Yonover GJ
    Valparaiso Univ Law Rev; 1998; 32(2):349-60. PubMed ID: 12710435
    [No Abstract]   [Full Text] [Related]  

  • 9. Shares in the human genome--the future of patenting DNA.
    Thomas SM; Hopkins MM; Brady M
    Nat Biotechnol; 2002 Dec; 20(12):1185-8. PubMed ID: 12454661
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of gene patenting on R&D and commerce.
    Stott M; Valentine J
    Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081
    [No Abstract]   [Full Text] [Related]  

  • 11. Intellectual property in higher life forms: the patent system and controversial technologies.
    Merges RP
    MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 13. The level of disclosure necessary for patent protection of genetic innovations.
    Berman RJ; El Schoenhard A
    Nat Biotechnol; 2004 Oct; 22(10):1307-8. PubMed ID: 15470468
    [No Abstract]   [Full Text] [Related]  

  • 14. The monster's laws: a legal history of chimera research.
    Appel JM
    Genewatch; 2006; 19(2):12-6. PubMed ID: 16789302
    [No Abstract]   [Full Text] [Related]  

  • 15. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
    Hoffman DC
    Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
    [No Abstract]   [Full Text] [Related]  

  • 16. Harvard squeaks through oncomouse patent appeal.
    Abbott A
    Nature; 2001 Nov; 414(6861):241. PubMed ID: 11713493
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent law--claim construction--U.S. District Court for the District of Massachusetts finds conflict on Federal Circuit and holds that product-by-process claims are not limited by their process steps. -- Trustees of Columbia University v. Roche Diagnostics GmbH, 126 F. Supp. 2d 16 (D. Mass. 2000).
    Harv Law Rev; 2002 Jan; 115(3):923-30. PubMed ID: 11958232
    [No Abstract]   [Full Text] [Related]  

  • 18. Rewriting the human prospect.
    Weber DO
    Healthc Forum J; 1993; 36(5):24-33. PubMed ID: 10130391
    [No Abstract]   [Full Text] [Related]  

  • 19. The Monsanto decision: the edge or the wedge.
    Gold ER; Adams WA
    Nat Biotechnol; 2001 Jun; 19(6):587. PubMed ID: 11385467
    [No Abstract]   [Full Text] [Related]  

  • 20. The strange case of the humanzee patent quest.
    Heathcotte B; Robert JS
    Natl Cathol Bioeth Q; 2006; 6(1):51-9. PubMed ID: 17037491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.